The FDA granted use authorizations for the OraSure kit used in conjunction with Hoffmann-La Roche molecular testing.
2 reports, 1 independent
Updated Sep 6
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA granted use authorizations for the OraSure kit used in conjunction with Hoffmann-La Roche molecular testing.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
OraSure Technologies
medical device company
Nothing else this week.
-
Hoffmann-La Roche
Swiss healthcare company
Related events
- FDA approval expands patient access to therapies for ACCORD.
- A company involving Oxford seeks FDA clearance for a new diagnostic test.
- FDA provided guidance for HCW Biologics' IND application.
- FDA approval enables commercial availability for a product associated with Indianapolis.
- Arise is seeking FDA approval for a drug as of October 7, 2026.